GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Awakn Life Sciences Corp (XCNQ:AWKN) » Definitions » Earnings per Share (Diluted)

Awakn Life Sciences (XCNQ:AWKN) Earnings per Share (Diluted) : C$-0.18 (TTM As of Jan. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Awakn Life Sciences Earnings per Share (Diluted)?

Awakn Life Sciences's Earnings per Share (Diluted) for the three months ended in Jan. 2024 was C$-0.04. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jan. 2024 was C$-0.18.

Awakn Life Sciences's EPS (Basic) for the three months ended in Jan. 2024 was C$-0.04. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jan. 2024 was C$-0.18.

Awakn Life Sciences's EPS without NRI for the three months ended in Jan. 2024 was C$-0.04. Its EPS without NRI for the trailing twelve months (TTM) ended in Jan. 2024 was C$-0.18.

During the past 3 years, the average EPS without NRIGrowth Rate was -73.60% per year.

During the past 4 years, Awakn Life Sciences's highest 3-Year average EPS without NRI Growth Rate was -73.60% per year. The lowest was -73.60% per year. And the median was -73.60% per year.


Awakn Life Sciences Earnings per Share (Diluted) Historical Data

The historical data trend for Awakn Life Sciences's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Awakn Life Sciences Earnings per Share (Diluted) Chart

Awakn Life Sciences Annual Data
Trend Jan21 Jan22 Jan23 Jan24
Earnings per Share (Diluted)
-0.05 -0.73 -0.39 -0.18

Awakn Life Sciences Quarterly Data
Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Earnings per Share (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.13 -0.06 -0.06 -0.02 -0.04

Competitive Comparison of Awakn Life Sciences's Earnings per Share (Diluted)

For the Biotechnology subindustry, Awakn Life Sciences's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Awakn Life Sciences's PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Awakn Life Sciences's PE Ratio distribution charts can be found below:

* The bar in red indicates where Awakn Life Sciences's PE Ratio falls into.



Awakn Life Sciences Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Awakn Life Sciences's Earnings Per Share (Diluted) for the fiscal year that ended in Jan. 2024 is calculated as

Diluted Earnings Per Share (A: Jan. 2024 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-5.103-0)/29.068
=-0.18

Awakn Life Sciences's Earnings Per Share (Diluted) for the quarter that ended in Jan. 2024 is calculated as

Diluted Earnings Per Share (Q: Jan. 2024 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(-1.116-0)/31.601
=-0.04

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


Awakn Life Sciences  (XCNQ:AWKN) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Awakn Life Sciences Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of Awakn Life Sciences's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Awakn Life Sciences (XCNQ:AWKN) Business Description

Traded in Other Exchanges
Address
301?217 Queen Street West, Toronto, ON, CAN, M5V 0R2
Awakn Life Sciences Corp is a clinical-stage biotechnology company intended to develop therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder. The Company focuses on Alcohol Use Disorder (AUD), a condition affecting the people in the US and key international markets and many people globally for which the current standard of care is inadequate, enabling to provide breakthrough therapeutics to addiction sufferers in desperate need.

Awakn Life Sciences (XCNQ:AWKN) Headlines

No Headlines